Literature DB >> 30773828

Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.

Anna D Protopopova1, Andrea Ramirez1,2, Dmitry V Klinov3, Rustem I Litvinov1,4, John W Weisel1.   

Abstract

Essentials Factor XIII is a heterotetramer with 2 catalytic A subunits and 2 non-catalytic B subunits. Structure of active and inactive factor XIII was studied with atomic force microscopy. Inactive factor XIII is made of an A2 globule and 2 flexible B subunits extending from it. Activated factor XIII separates into a B2 homodimer and 2 monomeric active A subunits.
SUMMARY: Background Factor XIII (FXIII) is a precursor of the blood plasma transglutaminase (FXIIIa) that is generated by thrombin and Ca2+ and covalently crosslinks fibrin to strengthen blood clots. Inactive plasma FXIII is a heterotetramer with two catalytic A subunits and two non-catalytic B subunits. Inactive A subunits have been characterized crystallographically, whereas the atomic structure of the entire FXIII and B subunits is unknown and the oligomerization state of activated A subunits remains controversial. Objectives Our goal was to characterize the (sub)molecular structure of inactive FXIII and changes upon activation. Methods Plasma FXIII, non-activated or activated with thrombin and Ca2+ , was studied by single-molecule atomic force microscopy. Additionally, recombinant separate A and B subunits were visualized and compared with their conformations and dimensions in FXIII and FXIIIa. Results and Conclusions We showed that heterotetrameric FXIII forms a globule composed of two catalytic A subunits with two flexible strands comprising individual non-catalytic B subunits that protrude on one side of the globule. Each strand corresponds to seven to eight out of 10 tandem repeats building each B subunit, called sushi domains. The remainder were not seen, presumably because they were tightly bound to the globular A2 dimer. Some FXIII molecules had one or no visible strands, suggesting dissociation of the B subunits from the globular core. After activation of FXIII with thrombin and Ca2+ , B subunits dissociated and formed B2 homodimers, whereas the activated globular A subunits dissociated into monomers. These results characterize the molecular organization of FXIII and changes with activation.
© 2019 International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  atomic force microscopy; blood; blood coagulation factor; factor XIII; transglutaminases

Mesh:

Substances:

Year:  2019        PMID: 30773828      PMCID: PMC6917434          DOI: 10.1111/jth.14412

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  56 in total

1.  Fibrinase. I. Purification of substrate and enzyme.

Authors:  A G LOEWY; K DUNATHAN; R KRIEL; H L WOLFINGER
Journal:  J Biol Chem       Date:  1961-10       Impact factor: 5.157

2.  Ozone-induced oxidative modification of plasma fibrin-stabilizing factor.

Authors:  Mark A Rosenfeld; Anna V Bychkova; Alexander N Shchegolikhin; Vera B Leonova; Marina I Biryukova; Elizaveta A Kostanova
Journal:  Biochim Biophys Acta       Date:  2013-08-12

3.  Structure of active coagulation factor XIII triggered by calcium binding: basis for the design of next-generation anticoagulants.

Authors:  Martin Stieler; Johannes Weber; Martin Hils; Peter Kolb; Andreas Heine; Christian Büchold; Ralf Pasternack; Gerhard Klebe
Journal:  Angew Chem Int Ed Engl       Date:  2013-09-20       Impact factor: 15.336

4.  Dissociation of the subunit structure of fibrin stabilizing factor during activation of the zymogen.

Authors:  L Lorand; A J Gray; K Brown; R B Credo; C G Curtis; R A Domanik; P Stenberg
Journal:  Biochem Biophys Res Commun       Date:  1974-02-27       Impact factor: 3.575

5.  Calcium-induced dissociation of human plasma factor XIII and the appearance of catalytic activity.

Authors:  R D Cooke
Journal:  Biochem J       Date:  1974-09       Impact factor: 3.857

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Spectroscopic study of secondary structure and thermal denaturation of recombinant human factor XIII in aqueous solution.

Authors:  A Dong; B Kendrick; L Kreilgârd; J Matsuura; M C Manning; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  1997-11-15       Impact factor: 4.013

Review 8.  Blood coagulation factor XIII and factor XIII deficiency.

Authors:  Akbar Dorgalaleh; Jamal Rashidpanah
Journal:  Blood Rev       Date:  2016-06-16       Impact factor: 8.250

9.  Human procarboxypeptidase U, or thrombin-activable fibrinolysis inhibitor, is a substrate for transglutaminases. Evidence for transglutaminase-catalyzed cross-linking to fibrin.

Authors:  Z Valnickova; J J Enghild
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

10.  Denaturation-renaturation of the fibrin-stabilizing factor XIII a-chain isolated from human placenta. Properties of the native and reconstituted protein.

Authors:  U Rinas; B Risse; R Jaenicke; K J Abel; G Zettlmeissl
Journal:  Biol Chem Hoppe Seyler       Date:  1990-01
View more
  3 in total

1.  The Structure of Blood Coagulation Factor XIII Is Adapted to Oxidation.

Authors:  Alexandra Vasilyeva; Lyubov Yurina; Alexander Shchegolikhin; Maria Indeykina; Anna Bugrova; Alexey Kononikhin; Eugene Nikolaev; Mark Rosenfeld
Journal:  Biomolecules       Date:  2020-06-17

2.  Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a).

Authors:  Ralf Pasternack; Christian Büchold; Robert Jähnig; Christiane Pelzer; Michael Sommer; Andreas Heil; Peter Florian; Götz Nowak; Uwe Gerlach; Martin Hils
Journal:  J Thromb Haemost       Date:  2019-10-23       Impact factor: 5.824

3.  The Plasma Factor XIII Heterotetrameric Complex Structure: Unexpected Unequal Pairing within a Symmetric Complex.

Authors:  Sneha Singh; Alexis Nazabal; Senthilvelrajan Kaniyappan; Jean-Luc Pellequer; Alisa S Wolberg; Diana Imhof; Johannes Oldenburg; Arijit Biswas
Journal:  Biomolecules       Date:  2019-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.